Home›Stock Screener›Vaxtex Cotfab›Financial Statements

Vaxtex Cotfab Financial Statements

12 Years of Data
2026 - 2015

Vaxtex Cotfab financial statements. In FYNone, Vaxtex Cotfab (VCL) reported revenue ₹14 Cr, net profit ₹5 Cr and EPS ₹0.30, with a net profit margin of 42.9% and ROE of 27.3%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Read VCL ex-dividend dates for the complete payout history and dividend yield track record.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 42.86% 2026 data
EBITDA Margin 35.71% 2026 data
Operating Margin 17.00% 2026 data
Return on Assets 16.22% 2026 data
Return on Equity 27.27% 2026 data

Balance Sheet Ratios

Current Ratio 18.00 2026 data
Equity Ratio 59.46% 2026 data
Asset Turnover 0.38 2026 data

VCL Revenue, Net Profit & EBITDA — Year-on-Year Growth

VCL YoY (March 2026 vs Period), net profit -16.7%. Analyse VCL institutional holdings to track promoter, FII and institutional holdings.

Net Profit Growth
-16.7%
Year-over-Year
Assets Growth
-24.5%
Year-over-Year
Equity Growth
+22.2%
Year-over-Year
Operating Cash Flow Growth
-300.0%
Year-over-Year
Investing Cash Flow Growth
+700.0%
Year-over-Year
Financing Cash Flow Growth
-300.0%
Year-over-Year

VCL Income Statement — Revenue, EBITDA & Net Profit

Vaxtex Cotfab revenue ₹14 Cr, EBITDA ₹5 Cr, net profit ₹5 Cr, EPS ₹0.30 (None) — net profit margin 42.9%. For live price, earnings ratios and company overview, see Vaxtex Cotfab share price today.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016
Revenue 14 14 6 17 77 62 26 28 22 18 5 1
Expenses 9 9 6 26 76 59 25 26 21 18 4 1
EBITDA 5 5 1 -9 1 3 2 1 1 0 0 0
Operating Profit Margin % 5.00% 17.00% -10.00% -54.00% -1.00% 5.00% 5.00% 5.00% 4.00% 2.00% -2.00% -3.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 1 1 1 1 0 0 0 0
Profit Before Tax 5 5 0 -9 1 2 0 0 1 0 0 0
Tax 0 -1 -1 0 0 1 0 0 0 0 0 0
Net Profit 5 6 1 -9 1 2 0 0 1 0 0 0
Earnings Per Share (₹) 0.30 0.30 0.05 -0.56 0.11 0.15 0.30 0.15 14.96 4.24 0.46 0.19

VCL Balance Sheet — Assets, Liabilities & Shareholders' Equity

VCL total assets ₹37 Cr, total equity ₹22 Cr, total liabilities ₹ Cr (2026) — ROE 27.3%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
ASSETS
Total Assets 37 49 49 70 24 22 28 14 10 5 4
Current Assets 36 41 42 66 20 18 17 7 9 4 4
Fixed Assets 0 1 1 4 4 4 2 2 2 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 0 8 7 1 1 0 0 0 0 0 0
Other Assets 37 40 41 65 19 18 26 12 8 4 4
LIABILITIES
Total Liabilities
Current Liabilities 2 7 10 5 6 10 9 3 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 22 18 19 24 10 9 9 5 4 4 4
Share Capital 18 18 18 13 10 6 6 0 0 0 0
Reserves & Surplus 4 0 0 11 0 3 3 4 4 4 4

VCL Cash Flow Statement — Operating, Investing & Financing

Vaxtex Cotfab operating cash flow ₹-2 Cr, investing ₹6 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -2 1 -48 -11 7 1 -7 2 2 -3 0 0
Investing Activities 6 -1 30 0 -4 2 -5 -5 -1 3 0 0
Financing Activities -4 -1 18 11 -3 -3 12 3 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0 0 0